The use of glatiramer acetate in the treatment of multiple sclerosis.

Advances in neurology

Volumn 98, Issue , 2006, Pages 273-292

  Wolinsky, Jerry S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLATIRAMER; IMMUNOSUPPRESSIVE AGENT; PEPTIDE;

CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DRUG EFFECT; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; STATISTICS; T LYMPHOCYTE; TREATMENT OUTCOME;

CENTRAL NERVOUS SYSTEM; CLINICAL TRIALS; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PEPTIDES; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 33644846142     PISSN: 00913952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)